| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.51 | 3e-35 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-10 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |